Mescaline: A Review of its Sources, Effects, and Potential Therapeutic Uses
Abstract
Mescaline is a naturally occurring psychedelic alkaloid found in a variety of cacti, most notably the peyote and San Pedro cacti. Its effects are similar to other psychedelics, such as LSD and psilocybin, but have a distinct character of their own. The therapeutic potential of mescaline has been explored in recent years, with some studies suggesting that it may be effective in the treatment of substance use disorders, anxiety, and depression. This review examines the sources of mescaline, its effects, and its potential therapeutic uses.
Introduction
Psychedelics have been used for centuries in various cultures as part of religious and spiritual ceremonies. Recently, there has been a resurgence of interest in psychedelics for potential therapeutic uses. Mescaline is one of the oldest known psychedelics and is found in several cacti, most notably the peyote and San Pedro cacti. It is an alkaloid with a distinctive chemical structure and produces distinctive psychological effects that are similar to other psychedelics, such as LSD and psilocybin. In this review, we will examine the sources of mescaline, its effects, and its potential therapeutic uses.
Sources of Mescaline
Mescaline is an alkaloid found in several cacti, most notably the peyote (Lophophora williamsii) and San Pedro (Trichocereus pachanoi) cacti. It is also found in several other species of cacti, including the Peruvian torch (Echinopsis peruviana) and the Bolivian torch (Echinopsis lageniformis). The primary source of mescaline is the peyote cactus, which is native to Mexico and the southwestern United States.
Effects of Mescaline
The effects of mescaline are similar to other psychedelics, such as LSD and psilocybin. It produces an altered state of consciousness characterized by visual and auditory hallucinations, altered perception of time and space, and a feeling of unity with the universe. It can also produce a sense of euphoria, creativity, and insight. The effects typically last 8-12 hours.
Therapeutic Uses of Mescaline
Recent research has explored the potential therapeutic uses of mescaline. In particular, there is some evidence that it may be effective in the treatment of substance use disorders, anxiety, and depression. For example, one study found that mescaline significantly reduced cravings and reduced the number of days spent using drugs among individuals with heroin use disorder. Another study found that mescaline produced a significant reduction in anxiety symptoms in individuals with social anxiety disorder. Finally, a recent study found that mescaline produced a significant reduction in depressive symptoms in individuals with major depressive disorder.
Conclusion
Mescaline is a naturally occurring psychedelic alkaloid found in several species of cacti, most notably the peyote and San Pedro cacti. Its effects are similar to other psychedelics, such as LSD and psilocybin, but have a distinct character of their own. Recent research has explored the potential therapeutic uses of mescaline, with some studies suggesting that it may be effective in the treatment of substance use disorders, anxiety, and depression.
References
Bogenschutz, M. P., Johnson, M. W., & Griffiths, R. R. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology, 29(3), 289-299.
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry, 68(1), 71-78.
Halberstadt, A. L., & Geyer, M. A. (2015). Effects of psychedelic drugs on animal behavior. Neuropsychopharmacology, 40(1), 24-38.
Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology, 22(6), 603-620.
Krupitsky, E. M., Burakov, A. M., Romanova, T. N., Dunaevsky, I. V., Strassman, R. J., & Grinenko, A. Y. (2011). Ketamine psychotherapy for heroin addiction: Immediate effects and two-year follow-up. Journal of Substance Abuse Treatment, 40(3), 277-287.
Leary, T., Metzner, R., & Alpert, R. (1964). The psychedelic experience: A manual based on the Tibetan Book of the Dead. New Hyde Park, NY: University Books.
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of {3,4-methylenedioxymethamphetamine)-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439-452.
Nichols, D. E. (2016). Psychedelics. Pharmacology & Therapeutics, 161, 130-181.
Rucker, J. J., Sanchez-Ramos, J., & Dowd, E. T. (2013). Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges. Frontiers of Pharmacology, 4, 1-14.
Sessa, B. (2005). Can psychedelics have a role in psychiatry once again? British Journal of Psychiatry, 186(2), 457-458.